Erratum to: Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients (Cancer Chemotherapy and Pharmacology (2011) DOI: 10.1007/s00280-011-1594-z)

Carlo Buonerba, Piera Federico, Carmine D'Aniello, Pasquale Rescigno, Carla Cavaliere, Livio Puglia, Matteo Ferro, Vincenzo Altieri, Sisto Perdonà, Sabino De Placido, Giuseppe Di Lorenzo

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1463
Number of pages1
JournalCancer Chemotherapy and Pharmacology
Volume67
Issue number6
DOIs
Publication statusPublished - Jun 2011

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pharmacology
  • Pharmacology (medical)
  • Toxicology

Cite this